Join
Live feed
·
INSIDERFilingvia Quantisnow
Neumora Therapeutics Inc. logo

Director Ho Maykin was granted 20,100 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NMRA· Neumora Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NMRA (Neumora Therapeutics Inc.) and more on Quantisnow.